03 AbbVie Inc .

Listing : ( NYSE : ABBV )

AbbVie Inc . is a top pharmaceutical name . The company has entered the race for oral interferon-free combination therapies for hepatitis C and recently finished its phase three clinical-trial program for its all-oral hepatitis C drug . AbbVie closed on Aug . 15 at $ 53.90 . www . abbvie . com